Quest Diagnostics Basic EPS 2010-2024 | DGX

Quest Diagnostics annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Quest Diagnostics basic eps for the quarter ending September 30, 2024 was $2.01, a 1.01% increase year-over-year.
  • Quest Diagnostics basic eps for the twelve months ending September 30, 2024 was $7.52, a 10.59% increase year-over-year.
  • Quest Diagnostics annual basic eps for 2023 was $0.008B, a 6.3% decline from 2022.
  • Quest Diagnostics annual basic eps for 2022 was $0.008B, a 48.9% decline from 2021.
  • Quest Diagnostics annual basic eps for 2021 was $0.016B, a 49.25% increase from 2020.
Quest Diagnostics Annual Basic EPS
2023 $7.59
2022 $8.10
2021 $15.85
2020 $10.62
2019 $6.36
2018 $5.39
2017 $5.63
2016 $4.58
2015 $4.92
2014 $3.83
2013 $5.58
2012 $3.49
2011 $2.95
2010 $4.08
2009 $3.91
Quest Diagnostics Quarterly Basic EPS
2024-09-30 $2.01
2024-06-30 $2.05
2024-03-31 $1.74
2023-12-31 $1.72
2023-09-30 $1.99
2023-06-30 $2.08
2023-03-31 $1.80
2022-12-31 $0.93
2022-09-30 $2.20
2022-06-30 $2.00
2022-03-31 $2.97
2021-12-31 $3.17
2021-09-30 $4.11
2021-06-30 $5.05
2021-03-31 $3.52
2020-12-31 $4.30
2020-09-30 $4.20
2020-06-30 $1.38
2020-03-31 $0.74
2019-12-31 $1.88
2019-09-30 $1.59
2019-06-30 $1.67
2019-03-31 $1.22
2018-12-31 $0.93
2018-09-30 $1.56
2018-06-30 $1.60
2018-03-31 $1.30
2017-12-31 $1.86
2017-09-30 $1.18
2017-06-30 $1.40
2017-03-31 $1.19
2016-12-31 $1.11
2016-09-30 $1.37
2016-06-30 $1.38
2016-03-31 $0.72
2015-12-31 $1.31
2015-09-30 $2.37
2015-06-30 $0.82
2015-03-31 $0.42
2014-12-31 $1.30
2014-09-30 $0.89
2014-06-30 $0.92
2014-03-31 $0.72
2013-12-31 $0.95
2013-09-30 $2.70
2013-06-30 $1.07
2013-03-31 $0.86
2012-12-31 $0.35
2012-09-30 $1.02
2012-06-30 $1.12
2012-03-31 $1.00
2011-12-31 $1.17
2011-09-30 $1.08
2011-06-30 $1.03
2011-03-31 $-0.33
2010-12-31 $0.96
2010-09-30 $1.14
2010-06-30 $1.08
2010-03-31 $0.90
2009-12-31 $0.99
2009-09-30 $1.03
2009-06-30 $1.01
2009-03-31 $0.88
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.912B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00